45°
Both Darst and Landes lost their mothers to cancer and share a commitment to uncovering innovative methods for treating cancer with reduced side effects.
ACGT, the nation’s only nonprofit dedicated exclusively to cell and gene therapies for cancer, funds top physicians and researchers at medical institutions in the U.S. and Canada. The foundation supports a number of gene therapy treatment,s including immunotherapy, which activates patients’ own immune systems to battle cancerous cells.
Darst, a 32-year-old New York City resident, is a graduate of Harvard College and Harvard Business School. Darst has held positions with Pfizer, Orbimed Advisors and a slate of other companies that are working to develop and finance new drugs in the biotech industry. Darst is currently the CEO at Rgenix, Inc., where he leads the company’s drug development initiatives and fundraising activities.
Landes, a 28-year-old Pacific Palisades, Calif., resident, is a graduate of Tufts University. Landes is executive director of Wendy Walk, a national nonprofit named for her late mother that has raised $2 million since 2010 to combat liposarcoma. Landes is an accomplished development professional who has held leadership and board positions at the Metropolitan Council, Seeds of Peace and the New York City Public Advocate's Office.
“David has that rare expertise of identifying how new, creative treatments dovetail with financing and fundraising,” said Barbara Netter, co-founder and president of ACGT. “Alexandra has a deep commitment to the cause and a profound understanding of how immunotherapy can revolutionize the way we treat cancer. Together, David and Alexandra will help to further introduce ACGT’s mission to younger supporters and advocates.”
Click here to follow Daily Voice Stamford and receive free news updates.
